CDKN2A Mutations and Melanoma Risk in the Icelandic Population

BACKGROUND: Germline CDKN2A mutations have been observed in 20-40% of high-risk melanoma-prone families, however little is known about their prevalence in population-based series of melanoma cases and controls. METHODS: We resequenced the CDKN2A gene, including the p14ARF variant and promoter region...

Full description

Saved in:
Bibliographic Details
Main Authors: Goldstein, Alisa M., Stacey, Simon N., Olafsson, Jon H., Jonsson, Gudbjörn F., Helgason, Agnar, Sulem, Patrick, Sigurgeirsson, Bardur, Benediktsdottir, Kristrun R., Thorisdottir, Kristin, Ragnarsson, Rafn, Kjartansson, Jens, Kostic, Jelena, Masson, Gisli, Kristjansson, Kristleifur, Gulcher, Jeffrey R., Kong, Augustine, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Tucker, Margaret A., Stefansson, Kari
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236640/
https://ncbi.nlm.nih.gov/pubmed/18178632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2007.055376
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items